Usana Health Sciences (USNA) Interest & Investment Income (2010 - 2026)

Usana Health Sciences (USNA) has reported Interest & Investment Income for 17 consecutive years, with $437000.0 the latest figure, recorded in Q2 2026.

• In Q2 2026, Interest & Investment Income fell 39.56% year-over-year to $437000.0; the TTM figure through Apr 2026 stood at $2.1 million (down 77.27% YoY), while the FY2026 annual figure was $2.4 million, down 78.66% from the prior year.
• Interest & Investment Income declined to $437000.0 in Q2 2026 per USNA's latest filing, from $495000.0 in the prior quarter.
• Across five years, Interest & Investment Income topped out at $3.1 million in Q3 2024 and bottomed at $437000.0 in Q2 2026.
• Historically, Interest & Investment Income has averaged $1.6 million across 5 years, with a median of $1.2 million in 2022.
• Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 230.46% — and 2026, when it plunged 81.92%.
• Usana Health Sciences' Interest & Investment Income stood at $1.5 million in 2022, then surged by 99.11% to $2.9 million in 2023, then retreated by 5.75% to $2.7 million in 2024, then plunged by 78.89% to $578000.0 in 2025, then fell by 24.39% to $437000.0 in 2026.
• Business Quant data shows USNA's Interest & Investment Income at $437000.0 in Q2 2026, $495000.0 in Q1 2026, and $578000.0 in Q3 2025.